Logo
Search
Login
Sign Up

Subscribe to our free newsletter

Stay up to date with our latest posts.

Risk in the biohacking game isn’t what you think it is

Risk in the biohacking game isn’t what you think it is

Unknowns matter more than side effects.

Feb 25, 2026

Why Reddit stacks outpace clinical science

Why Reddit stacks outpace clinical science

The internet optimizes for novelty. Biology doesn’t.

Feb 24, 2026

The uncomfortable truth about self-experimentation

The uncomfortable truth about self-experimentation

Most people aren’t actually biohackers. They’re improvising.

Feb 23, 2026

You don’t need more compounds

You don’t need more compounds

You need tighter variables.

Feb 21, 2026

1 week left — Discord peptide giveaway

1 week left — Discord peptide giveaway

Your chance to win $500 APR gift card. Discord-only. No raffle.

Feb 21, 2026

Most people experimenting have no model

Most people experimenting have no model

Copying a stack isn’t a protocol.

Feb 20, 2026

The peptide bubble isn’t what you think

The peptide bubble isn’t what you think

Hype cycles don’t kill molecules. Ignorance does.

Feb 19, 2026

GLP-1 isn’t about appetite

GLP-1 isn’t about appetite

It’s about metabolic command centers.

Feb 18, 2026

The research compound grey market reality

The research compound grey market reality

Risk doesn’t disappear just because people ignore it.

Feb 17, 2026

Peptides just crossed into the mainstream

Peptides just crossed into the mainstream

That changes the responsibility.

Feb 16, 2026

What Survives Regulatory Pressure

What Survives Regulatory Pressure

When enforcement rises, weak suppliers disappear.

Feb 13, 2026

Why Compounding Pharmacies Are Disappearing

Why Compounding Pharmacies Are Disappearing

The biggest shift in peptide access isn’t hype. It’s enforcement.

Feb 12, 2026

The Peptide Industry Just Changed

The Peptide Industry Just Changed

2026 is not business as usual. Here’s what’s happening.

Feb 11, 2026

The real risk with GLP-1 peptides

The real risk with GLP-1 peptides

It’s not nausea. It’s using powerful signals without context.

Feb 10, 2026

Fat loss peptides don’t burn fat

Fat loss peptides don’t burn fat

They change fuel selection.

Feb 9, 2026

Why dual- and triple-agonists outperform semaglutide

Why dual- and triple-agonists outperform semaglutide

It’s not “stronger.” It’s wider signal coverage.

Feb 8, 2026

GLP-1s didn’t change fat loss. They changed fuel selection.

GLP-1s didn’t change fat loss. They changed fuel selection.

Feb 7, 2026

Repair peptides aren’t upgrades

Repair peptides aren’t upgrades

They fix damage. They don’t raise the ceiling.

Feb 6, 2026

“Research use only” doesn’t mean what you think

“Research use only” doesn’t mean what you think

The FDA just made that painfully clear.

Feb 5, 2026

Why Peptides Fail Without Context

Why Peptides Fail Without Context

Most peptide failures aren’t about the peptide

Feb 3, 2026

Don’t gamble with your biomarkers

Don’t gamble with your biomarkers

This is the difference between optimizing and hoping.

Feb 2, 2026

The easiest way to run 100+ labs yearly

The easiest way to run 100+ labs yearly

No spreadsheets. No guessing. Just feedback loops.

Feb 1, 2026

Load more

Biohacker Network

© 2026 Biohacker Network.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv